Provider P15-17 Change to Administration of Interpreter Services for MHCP Subscribers - Opens in a new window Read More - Opens in a new window
Provider P59-16 Organization Determination Additions for Platinum Blue - Effective January 23, 2017 - Opens in a new window Read More - Opens in a new window
Provider P51-16 Addition of a Drug (Belviq XR) to the Weight Loss Agents Prior Authorization with Quantity Limit Program - Opens in a new window Read More - Opens in a new window
Provider P58-16 Changes to Prior Authorization for Infertility for Commercial Lines of Business - Opens in a new window Read More - Opens in a new window
Provider P20-17 New Drug-Related Prior Authorization Criteria for QVAR (beclomethasone dipropionate HFA) - Opens in a new window Read More - Opens in a new window
Provider P10-17 Changes in Medical Policy IV-122 Knee Arthroplasty (Knee Replacement) - Opens in a new window Read More - Opens in a new window
Provider P61-16 New Drug-Related Prior Authorization Criteria for Amitiza and Linzess - Opens in a new window Read More - Opens in a new window
Provider P52-16 DHS Guidelines for Mental Health-Targeted Case Management Services for MHCP Subscribers - Opens in a new window Read More - Opens in a new window
Provider P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents - Opens in a new window Read More - Opens in a new window
Provider P62-16 EY Modifier for Platinum Blue Subscribers - Opens in a new window Read More - Opens in a new window